This systematic review of 9 studies confirms that under-correction of myopia does not slow progression; rather, at least half of the studies have shown the myopia progression is accelerated. There was no benefit found in overcorrection, and the evidence for un-correction was equivocal. Clinically, this advocates for the full correction of myopia.
During the COVID-19 pandemic, governments imposed home confinement and school-based learning was the normal. Has this caused more myopia? In this clinical case, the unique environment of lockdown is explored in view of myopia management outcomes.
How should you best manage children with unilateral or anisometropic myopia? Learn about what drives aniso-myopic development, associations with amblyopia and ocular pathology, and the evidence base for orthokeratology to slow aniso-myopic eye growth.
What amount of axial length growth be expected in myopes versus emmetropes, and how can you tell if your myopia control treatment is working? This important clinical reference provides all this information and more on axial growth in younger and older children, emmetropes and myopes, and even data on typical myopia stabilization.
Managing myopia in presbyopic adults has specific goals in achieving good vision correction and best eye health outcomes. What should we consider if myopia progression is observed? This article explores progression, the ideal optical correction and ocular health considerations in presbyopic myopes.
Orthokeratology has been well established as a myopia control treatment. The newest research in orthokeratology has investigated compliance, safety, comfort and combination treatment with atropine. Here, we’ll bring you the latest knowledge with implications for clinical practice.
Children, teens and adults with high myopia need special consideration of not just myopia control, but the best type of myopia correction and the importance of ocular health management. Do high myopes progress more quickly? What are the risks and management options?
Which clinical tests are required for myopia management? Here we take you through the recommendations of the International Myopia Institute (IMI) Clinical Management Guidelines Report, with references to several more of the IMI Reports including the latest Volume in 2021. You have everything you need to get started – learn more here.
The Erasmus Medical Group in the Netherlands set out four steps in their myopia management protocol: providing visual environment advice, identifying high-risk myopes by axial length and treating them with atropine 0.5%, managing other myopes with optical treatments or lower-concentration atropine, and ceasing treatment in the late teens once axial length is stable. The described use of axial length percentile growth charts for diagnosis, choice of treatment, monitoring and cessation is a world-first.
Growth charts are commonly used in childhood health and are easily understood by parents. When applied to myopia management, axial length growth charts can allow individualized decisions on treatment strategy and efficacy. What charts are available now and how can you use them in practice? Here we explain how to use axial length growth charts from initial diagnosis to treatment strategy and long term monitoring.
